BIOSCEPTRE

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke BIOSCEPTRE wurde als Wortmarke am 13.12.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 31. Mai 2023

Markenform Wortmarke
Aktenzeichen 1726400
Länder Europäische Gemeinschaft Japan Vereinigte Staaten von Amerika (USA)
Basismarke AU Nr. 2279232, 24. Juni 2022
Anmeldedatum 13. Dezember 2022
Ablaufdatum 13. Dezember 2032

Markeninhaber

1 Rivett Road
North Ryde NSW 2113
AU

Markenvertreter

PO BOX R1791 ROYAL EXCHANGE NSW 1225 AU

Waren und Dienstleistungen

05 Biopharmaceutical and pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; veterinary preparations; biological preparations for veterinary purposes; cultures of microorganisms for medical and veterinary use; biological preparations for medical purposes; drugs for medical purposes; diagnostic preparations for medical purposes; enzymes for medical purposes; biochemical medicines; vaccines; bioengineering pharmaceutical solutions for use in expanding cells for therapeutic use to patients with blood cancers and other diseases; biopharmaceuticals; cells and biological preparations intended for medical and clinical use, including, blood, stem cells, adult blood cells, immune cells, immunomodulatory cells, umbilical cord cells, umbilical cord blood, and placental tissue; bioengineered cells for use in immunotherapies; diagnostic materials and diagnostic preparations for medical purposes; gene and cell therapy and prophylaxis products; gene and cell therapy prophylaxis vector preparations for therapeutic purposes; pharmaceutical preparations and products; pharmaceutical preparations in the nature of cell solutions to enable cell expansion for therapeutic purposes; reagents for ex vivo cell processing in particular media suitable for the expansion of cells for therapeutic purposes; cell products for therapeutic purposes, including stem and progenitor cell, adult cell, immune cell, cell therapy and gene therapy products; cells for medical purposes
42 Analysis of biological samples; biopharmaceutical and pharmaceutical development and research and evaluation services in the field of cell based therapeutics and gene therapy for the treatment of disease, injuries and disorders; biotechnology laboratory services; medical and scientific laboratory services; scientific, medical and clinical research consultation services and scientific, medical and clinical research and development services, including in the field of haematology, immunology, cancer research, developmental biology and life sciences, biotechnology, medical technology, cell culture, tissue engineering, genetic engineering, regenerative medicine, immunotherapy and immunomodulation; pre-clinical and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical analysis; industrial design; conducting technical project studies; research and development of new products for others; material testing; biological research; scientific laboratory services; scientific research; bacteriological research
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
13. Dezember 2022 2023/15 Gaz AU Eintragung

ID: 141726400